CCM
CELU icon

Context Capital Management’s Celularity CELU Stock Holding History

Context Capital Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-30,000
Closed -$3.15M – 263
2020
Q3 		$3.15M Buy
+30,000
New +$3.11M 0.68% 52

Other funds holding CELU

BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return

Context Capital Management's CELU Position: Q4 2020 in Review

Context Capital Management sold out of Celularity (CELU) in Q4 2020, closing a stake of 30,000 shares — an estimated $3.15M sold.

Context Capital Management first reported a position in CELU in Q3 2020 and held it in 1 quarter. The position peaked at $3.15M in Q3 2020. 64 funds tracked by Wall St. Rank hold CELU as of Q4 2020.

  • Context Capital Management reported no remaining Celularity position as of Q4 2020 after selling out during the quarter.
  • Context Capital Management sold 30,000 Celularity shares in Q4 2020, an estimated $3.15M.
  • Context Capital Management first reported a position in Celularity in Q3 2020 and held it in 1 quarter.
  • Context Capital Management's Celularity position peaked at $3.15M in Q3 2020.
  • 64 funds tracked by Wall St. Rank held Celularity as of Q4 2020.

Based on Context Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.